A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

June 19, 2012

Primary Completion Date

December 2, 2013

Study Completion Date

December 2, 2013

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

peficitinib

oral

DRUG

Placebo

oral

Trial Locations (38)

1027

Budai Irgalmasrendi Korhaz, Budapest

Orszgos Reumatolgiai s Fizioterpis Intzet, Budapest

Revita Clinic Rheumatology, Budapest

1612

"MHAT Sv. Ivan Rilski", Sofia

4003

MHAT Plovdiv AD, Plovdiv

5600

Rethy Pal Korhaz es Rendelointezet, Békéscsaba

6700

Cliditer S.A. de C.V., Mexico City

8000

MHAT Burgas, Burgas

16635

Altoona Center for Clinical Research, Duncansville

19610

Clincal Research Center of Reading, Wyomissing

20902

The Center for Rheumatology and Bone Research, Wheaton

26301

Mountain State Clinical Research, Clarksburg

28602

PMG Research, Hickory

32216

Jacksonville Center for Clinical Research, Jacksonville

32804

Arthritis Associates, Orlando

35216

Achieve Clinical Research, LLC, Birmingham

42701

Center for Arthritis and Osteoporosis, Elizabethtown

44650

Dr Javier Orozco Alcala Private Doctor´s office, Guadalajara

58070

Centro de Investigacion Clinica de Morelia, S.C., Morelia

60053

Illinois Bone & Joint Institute; LLC, Morton Grove

60061

Deerbrook Medical Asssociates, Vernon Hills

68601

MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o., Uherské Hradiště

73103

Health Research of Oklahoma, Oklahoma City

78705

Austin Rheumatology Research PA, Austin

80910

Arthritis Associates of Colorado Springs, Colorado Springs

92260

Desert Medical Advances, Palm Desert

93454

Pacific Arthritis Center Medical Group, Santa Maria

94304

Stanford University School of Medicine, Palo Alto

92093-0943

University of California San Diego, La Jolla

37909-1907

Rheumatology Consultants, PLLC, Knoxville

128 50

Revmatologicky ustav, Prague

140 00

Revmatologicka ambulance, Praha-Nusle

760 01

PV-MEDICAL s.r.o., Zlín

H-4043

Kenezy Hospital Institute of Clinical Pharmacology, Debrecen

85-168

Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela, Bydgoszcz

31-637

NZOZ Centrum Medyczne ProMiMed, Krakow

20-582

Zespol Poradni Specjalistycznych, REUMED sp. Zo.o, Lublin

02-653

ARS Rheumatica, Warsaw

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01565655 - A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter